MedTrace Logo

Comparison of Exparel to Marcaine in Post-Surgical Analgesia in Bariatrics

NCT02752230 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2020-07-15

No results posted yet for this study

Summary

This study is designed to evaluate the use of bupivacaine liposome 1.3% compared bupivacaine 0.5% in pain control in post-operative laparoscopic bariatric surgery patient The purpose of this study is to evaluate two local anesthetics and determine if there is an advantage of administering one medication compared over the other. The intent is show that one local anesthetic.allows for improved pain control as per the pain scale ratings of the test subjects.

Conditions

  • Post Operative Pain

Interventions

PROCEDURE

Laparoscopic Roux en Y gastric bypass

Laparoscopic Roux en Y gastric bypass

PROCEDURE

Laparoscopic Sleeve Gastrectomy

Laparoscopic Sleeve Gastrectomy

Sponsors & Collaborators

  • Kettering Health Network

    lead OTHER

Principal Investigators

  • Lauren Smith · Kettering Health Network

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-29
Primary Completion
2020-06-01
Completion
2021-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02752230 on ClinicalTrials.gov